[Correspondence] New clozapine regulations, old inequalities? | ClinicLens
Clozapine remains the most effective antipsychotic for treatment-resistant schizophrenia, yet its use continues to be restricted by mandatory haematological monitoring requirements. Although these monitoring programmes have substantially reduced mortality associated with clozapin
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.